A quantitative assay for measuring the induction of mutations in human peripheral blood T-lymphocytes.
We optimized conditions for propagating freshly-isolated human peripheral blood T-lymphocytes and cells that had been stored in liquid nitrogen on Day 5 post-isolation, exposing them to mutagens in exponential growth, and measuring the cytotoxicity of the agent from the loss of colony-forming ability, and its mutagenicity from the increase in frequency of 6-thioguanine-resistant cells. Supernatant containing T-cell growth factor, from 60Co-irradiated peripheral mononuclear cells cultured in the presence of 60Co-irradiated B-lymphoblastoid human cells as allogeneic stimulators, supplied at a concentration of 10% along with 10% serum and 10(5) allogeneic stimulator cells/ml, supported exponential growth (population doubling times of 22 h) for extended periods (greater than 30 d). It gave cloning efficiencies of greater than or equal to 40%. T-lymphocytes stored in liquid nitrogen and returned to culture shortly before mutagen exposure exhibited the same sensitivity as freshly-isolated T-cells to killing by the agents tested, i.e., UV radiation, ethyl-nitrosourea, and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,19 alpha,epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene. We showed that if mutagenized populations frozen during the expression period were thawed and assayed, they exhibited the same cloning efficiencies and frequencies of 6-thioguanine-resistant cells as did the corresponding populations that had been assayed directly without freezing. Use of these procedures should facilitate investigation of the frequency and kinds of mutations induced in the HPRT gene of peripheral blood T-lymphocytes in vivo and in vitro.
Norimura
T
T
Department of Microbiology, Michigan State University, East Lansing 48824-1316.
Maher
V M
VM
McCormick
J J
JJ
D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / Q000633:toxicity; D002455:Cell Division; D002478:Cells, Cultured; D004351:Drug Resistance / Q000235:genetics; D005038:Ethylnitrosourea / Q000633:toxicity; D005615:Freezing; D006801:Humans; D007376:Interleukin-2 / Q000032:analysis / Q000494:pharmacology; D009152:Mutagenicity Tests; D009154:Mutation; D013601:T-Lymphocytes / Q000166:cytology / Q000378:metabolism*; D013866:Thioguanine / Q000494:pharmacology
D007376:Interleukin-2; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D013866:Thioguanine; D005038:Ethylnitrosourea